Published in Virchows Arch A Pathol Pathol Anat on January 01, 1973
Evolution of liver transplantation. Hepatology (1982) 19.54
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene (1995) 13.86
Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res (1994) 10.72
Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (1985) 9.73
Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res (1999) 6.39
A classification of chronic hepatitis. Lancet (1968) 6.07
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell (1983) 5.79
Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem (1996) 5.42
Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature (1982) 4.44
Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein. Proc Natl Acad Sci U S A (1983) 4.38
The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J (1989) 4.27
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol (2001) 3.53
Cloning and expression of cDNA encoding mouse tyrosinase. Nucleic Acids Res (1986) 3.21
Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res (1985) 3.09
A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int (1996) 2.98
Asymmetrical recognition of the palindromic AP1 binding site (TRE) by Fos protein complexes. EMBO J (1989) 2.98
Ultrastructure of a periodic protein layer in the outer membrane of Escherichia coli. J Cell Biol (1977) 2.89
The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell (1989) 2.84
Shaker encodes a family of putative potassium channel proteins in the nervous system of Drosophila. EMBO J (1988) 2.70
Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J (1995) 2.67
Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res (2001) 2.65
Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699. Chem Biol (1998) 2.64
Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol (1971) 2.51
Induction of c-fos during myelomonocytic differentiation and macrophage proliferation. Nature (1985) 2.34
Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature (1984) 2.34
The structure of the RNA binding site of ribosomal proteins S8 and S15. J Biol Chem (1979) 2.24
Alternative splicing of human cyclin E. J Cell Sci (1994) 2.20
Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci U S A (1985) 2.18
Inducible regulatory elements in the human cyclin D1 promoter. Oncogene (1994) 2.16
Justification of the 4-mmol/l lactate threshold. Int J Sports Med (1985) 2.15
Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol Cell Biol (1983) 2.14
KDR receptor: a key marker defining hematopoietic stem cells. Science (1999) 2.13
Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J (1985) 2.11
Expression of c-onc genes: c-fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion. EMBO J (1983) 2.08
Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature (1987) 2.08
Drug assay using antibody mimics made by molecular imprinting. Nature (1993) 2.04
Specificity and localization of the hepatitis B virus-associated protein kinase. J Virol (1982) 2.00
trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation. Cell (1989) 2.00
Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. Eur J Biochem (1985) 1.99
Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J (1990) 1.97
Revising the preventive paradox: the Swiss case. Addiction (2001) 1.92
Cell cycle regulation of E2F site occupation in vivo. Science (1996) 1.90
Chronic spinal pain syndromes: a clinical pilot trial comparing acupuncture, a nonsteroidal anti-inflammatory drug, and spinal manipulation. J Manipulative Physiol Ther (1999) 1.88
An autonomous N-terminal transactivation domain in Fos protein plays a crucial role in transformation. EMBO J (1994) 1.83
Involvement of common and cell type-specific pathways in c-fos gene control: stable induction of cAMP in macrophages. Cell (1987) 1.83
Incorporation of [18O]water into 4-hydroxybenzoic acid in the reaction of 4-chlorobenzoate dehalogenase from pseudomonas spec. CBS 3. Biochem Biophys Res Commun (1984) 1.80
Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene (1994) 1.77
Purification and some properties of 2-halobenzoate 1,2-dioxygenase, a two-component enzyme system from Pseudomonas cepacia 2CBS. J Bacteriol (1992) 1.76
Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay. Methods Enzymol (1983) 1.76
Two functionally different regions in Fos are required for the sequence-specific DNA interaction of the Fos/Jun protein complex. Nature (1989) 1.74
Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene (1994) 1.73
Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes. EMBO J (1985) 1.73
Endothelial-like cells derived from human CD14 positive monocytes. Differentiation (2000) 1.73
Assessing forearm fracture risk in postmenopausal women. Osteoporos Int (2009) 1.71
Eutrophication causes speciation reversal in whitefish adaptive radiations. Nature (2012) 1.69
[Ampicillin--a semi-synthetic penicillin in pregnancy, the newborn and premature period]. Monatsschr Kinderheilkd (1968) 1.64
Multimodal imaging demonstrates concomitant changes in bone and cartilage after destabilisation of the medial meniscus and increased joint laxity. Osteoarthritis Cartilage (2010) 1.63
Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther (2001) 1.63
Differential expression of c-fos in hematopoietic cells: correlation with differentiation of monomyelocytic cells in vitro. EMBO J (1984) 1.63
Integration of transfected LTR sequences into the c-raf proto-oncogene: activation by promoter insertion. EMBO J (1985) 1.60
Electromagnetic interference of pacemakers by mobile phones. Pacing Clin Electrophysiol (1996) 1.60
Molecular structure of the bilin binding protein (BBP) from Pieris brassicae after refinement at 2.0 A resolution. J Mol Biol (1987) 1.58
Periodic cdc25C transcription is mediated by a novel cell cycle-regulated repressor element (CDE). EMBO J (1995) 1.54
Chemical composition of the attachment pad secretion of the locust Locusta migratoria. Insect Biochem Mol Biol (2002) 1.54
Tissue and cell type-specific expression of two human c-onc genes. Nature (1983) 1.53
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int (2009) 1.52
Regulation of c-fos transcription in mouse fibroblasts: identification of DNase I-hypersensitive sites and regulatory upstream sequences. EMBO J (1985) 1.51
Enzymatic dehalogenation of pentachlorophenol by extracts from Arthrobacter sp. strain ATCC 33790. J Bacteriol (1989) 1.50
New lessons for combinatorial biosynthesis from myxobacteria. The myxothiazol biosynthetic gene cluster of Stigmatella aurantiaca DW4/3-1. J Biol Chem (1999) 1.49
Human alpha2-macroglobulin: genotype-phenotype relation. Exp Neurol (2003) 1.47
Structure-function analysis of fos protein: a single amino acid change activates the immortalizing potential of v-fos. Cell (1987) 1.47
Structural and material approaches to bone tissue engineering in powder-based three-dimensional printing. Acta Biomater (2010) 1.46
Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J Cell Sci (1993) 1.46
Use of conditional promoters for expression of heterologous proteins in Saccharomyces cerevisiae. Methods Enzymol (1997) 1.45
Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell Sci (1993) 1.45
Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev (1991) 1.45
Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone (2007) 1.43
Wounding a fibroblast monolayer results in the rapid induction of the c-fos proto-oncogene. EMBO J (1986) 1.42
Expression of c-fos in NIH3T3 cells is very low but inducible throughout the cell cycle. EMBO J (1986) 1.41
IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol (2000) 1.41
Generation of infectious retrovirus aerosol through medical laser irradiation. Lasers Surg Med (1998) 1.39
High-dose intravascular beta-radiation after de novo stent implantation induces coronary artery spasm. Circulation (2002) 1.39
[Toy cap pistols and their effect on hearing]. HNO (1998) 1.39
Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J (1996) 1.37
Expression of cellular oncogenes. Curr Top Microbiol Immunol (1984) 1.36
Co-transfection of normal NIH/3T3 DNA and retroval LTR sequences: a novel strategy for the detection of potential c-onc genes. EMBO J (1984) 1.35
New fluorescent dyes in the red region for biodiagnostics. J Fluoresc (1995) 1.35
Characterization of a keratinolytic serine proteinase from Streptomyces pactum DSM 40530. Appl Environ Microbiol (1995) 1.35
Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res (2000) 1.35
The incidence of complications associated with local anesthesia in dentistry. Anesth Prog (1997) 1.34
Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. Nucleic Acids Res (1995) 1.31
Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer (1999) 1.31
The neuropathology of an infectious disease transmitted by African green monkeys (Cercopithecus aethiops). Ger Med Mon (1969) 1.30
Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med (2001) 1.30
Identification of a cis-acting dendritic targeting element in the mRNA encoding the alpha subunit of Ca2+/calmodulin-dependent protein kinase II. Eur J Neurosci (2001) 1.30
Psychological resources in spinal cord injury: a systematic literature review. Spinal Cord (2011) 1.30
[Chronic toxic liver lesions in the PVC (polyvinyl chloride)-producing workers]. Dtsch Med Wochenschr (1973) 1.30
Cellular and viral fos genes: structure, regulation of expression and biological properties of their encoded products. Biochim Biophys Acta (1986) 1.28
Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS (1996) 1.27
Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology (1996) 1.27